Celltrion
068270.KS
#808
Rank
S$33.01 B
Marketcap
$159.38
Share price
0.73%
Change (1 day)
-1.28%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Celltrion (068270.KS) - Cash on Hand

Cash on Hand as of March 2024 : S$0.92 Billion

According to Celltrion 's latest financial reports the company has S$0.92 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Celltrion - Cash on Hand chart (from 2007 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31S$0.63 B-54.4%
2021-12-31S$1.38 B62.99%
2020-12-31S$0.85 B16.17%
2019-12-31S$0.73 B12.39%
2018-12-31S$0.65 B-6.95%
2017-12-31S$0.69 B112.64%
2016-12-31S$0.32 B75.43%
2015-12-31S$0.18 B31.26%
2014-12-31S$0.14 B5.15%
2013-12-31S$0.13 B11.86%
2012-12-31S$0.12 B85.55%
2011-12-31S$65.49 M-53.4%
2010-12-31S$0.14 B424.4%
2009-12-31S$26.8 M455.34%
2008-12-31S$4.82 M-26.39%
2007-12-31S$6.55 M